UW-Madison Originated Regenerative Skin Tissue Product for Burn Wounds Performs Well in Phase III Clinical Trial

UW-Madison Originated Regenerative Skin Tissue Product for Burn Wounds Performs Well in Phase III Clinical Trial

Madison, WI-based Stratatech (part of UK-based Mallinckrodt) completed a study demonstrating burn wounds treated in the clinical trial mostly healed well and rarely required patient skin grafts in findings that will lead to an application for Food and Drug...

Pin It on Pinterest